[
  {
    "ts": null,
    "headline": "Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks",
    "summary": "As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the branded pharmaceuticals industry, including Corcept (NASDAQ:CORT) and its peers.",
    "url": "https://finnhub.io/api/news?id=dae6e819c210aed16814f753472dbffa3ab38f6cd3e30b6a528c0cf7b03fc302",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741079177,
      "headline": "Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks",
      "id": 133186672,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the branded pharmaceuticals industry, including Corcept (NASDAQ:CORT) and its peers.",
      "url": "https://finnhub.io/api/news?id=dae6e819c210aed16814f753472dbffa3ab38f6cd3e30b6a528c0cf7b03fc302"
    }
  },
  {
    "ts": null,
    "headline": "Top 50 High-Quality Dividend Stocks For March 2025",
    "summary": "Read here for nine attractively valued dividend stocks with detailed analysis and unique valuations. Stay ahead in 2025's market with expert insights.",
    "url": "https://finnhub.io/api/news?id=f1fd84764364d70ffd5f4581ba18b970e5cd587e629c6b6f93842680c8e41c2b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741048973,
      "headline": "Top 50 High-Quality Dividend Stocks For March 2025",
      "id": 132971204,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2150522257/image_2150522257.jpg?io=getty-c-w1536",
      "related": "ZTS",
      "source": "SeekingAlpha",
      "summary": "Read here for nine attractively valued dividend stocks with detailed analysis and unique valuations. Stay ahead in 2025's market with expert insights.",
      "url": "https://finnhub.io/api/news?id=f1fd84764364d70ffd5f4581ba18b970e5cd587e629c6b6f93842680c8e41c2b"
    }
  }
]